INTRODUCTION {#S1}
============

Normal blood pressure (BP) follows a circadian pattern, rising to the highest point in the morning and declining during sleeping periods. Nocturnal dipping is the measurement of BP decline during sleep periods compared to wake periods ([@R1]). Typically, BP declines ≥10% during sleep periods in most individuals, leading to the classification as "dippers." Individuals with \<10% BP decline are classified as "non-dippers" ([@R2]). Non-dippers have been shown to have increased cardiovascular mortality risks ([@R3]) and target organ damage ([@R4],[@R5]), including silent cerebrovascular damage ([@R6]) and kidney damage ([@R7]). Most studies examining nocturnal dipping have been performed in clinical populations such as those with hypertension, chronic kidney disease, and primary aldosteronism ([@R3],[@R5],[@R8]--[@R10]). However, Ohkubo et al ([@R3]) provided strong evidence that normotensives with diminished nocturnal dipping have increased cardiovascular risk compared to normotensives with normal nocturnal dipping.

Over a 24h period, BP is influenced by several external factors, including habitual activity, stress, and posture ([@R11]). Endogenous factors such as the autonomic nervous system & endocrine factors also influence BP ([@R12],[@R13]). Likewise dietary sodium has been shown to affect short- and long-term BP, as well as nocturnal BP dipping in several clinical populations ([@R9],[@R14],[@R15]). For example, sodium restriction improves BP dipping in patients with essential hypertension, chronic kidney disease, and hyperaldosteronism ([@R8]--[@R10],[@R16]). However, there are few studies that have examined the effect of dietary sodium on BP dipping in normotensive men and women ([@R14],[@R17]).

Therefore, the purpose of this study was to determine the effects of dietary sodium on BP dipping in normotensive adults. Because habitual sodium intake varies widely within the population ([@R18]), it was necessary to conduct a feeding study where sodium content was strictly controlled. We tested the hypothesis that a high sodium (HS) diet would blunt nocturnal dipping in normotensive adults compared to a low sodium (LS) diet. Participants first completed a standardized run-in (100 mmol sodium·day^−1^) diet before being randomized to a LS (20 mmol·day^−1^) or HS (300 mmol·day^−1^) diet. Participants consumed each diet for one week with nocturnal BP dipping assessed on the last day of each diet. Because there are known sex differences in BP regulation ([@R19]), our secondary hypothesis was that HS would blunt BP dipping more in men compared to women.

METHODS {#S2}
=======

Subjects {#S3}
--------

All experimental protocols were approved by the Institutional Review Board at the University of Delaware and were in compliance with guidelines set forth by the *Declaration of Helsinki*. Therefore, a total of 101 participants completed the controlled feeding study. Using the criteria of O'Brien et al. ([@R1]), we excluded participants if they did not have at least 15 daytime and 8 nocturnal BP measurements. Thus, the data presented herein are the 80 participants that had an adequate number of daytime and nocturnal BP measurements. Utilizing 80 participants allowed for the reliable detection (β\>0.80) of a small effect of dietary sodium on nocturnal BP dipping (d=0.133, α=0.05).

Prior to a screening visit, all participants provided both a verbal and written consent before entering the study. During the initial screening visit, participants completed a medical history questionnaire. A 12-lead electrocardiogram, resting brachial BP (Dinamap, Dash 2000; GE Medical Systems, Milwaukee, WI), height, weight, and a fasted blood sample were obtained. All 80 participants were healthy normotensive adults (22--59 years) with a resting systolic BP of \<140mmHg and a diastolic BP \<90mmHg. Study participants were free of any known cardiovascular disease, and had no evidence of renal, metabolic, pulmonary, or neurological diseases. Participants were non-obese (body mass index, BMI\<30 kg·m^−2^) and did not use nicotine products.

21-Day Controlled Feeding Study {#S4}
-------------------------------

All food was prepared by a registered dietitian. Participants first completed a standardized 7 day run-in (100.2±0.3 mmol sodium·day^−1^) diet. Immediately following the final day of the run-in diet, participants completed a 7 day LS (22.6±0.2 mmol·day^−1^) and a 7 day HS (309.5±3.6 mmol·day^−1^) diet in random order. Dietary potassium was controlled across all three diets (Run-in=69.4±1.2 mmol·day^−1^; LS=71.1±1.3 mmol·day^−1^, HS=69.8±1.3 mmol·day^−1^). In order to assure participants maintained a constant body weight throughout the controlled feeding study, energy content was appropriately adjusted using the Mifflin-St Jeor equation ([@R20]); therefore all diets were designed to be eucaloric. The macronutrient content was comprised of \~50% carbohydrate, \~30% fats, and \~20% protein. Participants were instructed to consume all of the provided food. Due to the robust differences in dietary sodium content, it was not possible to blind the participants.

Ambulatory Blood Pressure Monitoring {#S5}
------------------------------------

On the final day of each diet, participants wore a 24h ambulatory BP monitor (Model 90207; Spacelabs Medical, Issaquah, WA, USA) properly fitted for each individuals' non-dominant arm size, as recommended by the manufacturer. Participants were instructed to maintain their daily activities and refrain from exercise and caffeine. Participants were instructed to maintain their normal waking and sleeping patterns on the final day of each diet and monitors were set accordingly to capture wake and sleep periods. BP was taken every 20 minutes during waking periods and every 30 minutes during sleeping periods. The relatively high frequency BP measurements allows for reliable week to week ambulatory BP measures, as previously demonstrated ([@R21]).

In order to reliably measure nocturnal dipping, ≥15 BP measurements were needed during wake periods, and ≥8 BP measurements were needed during sleep periods under each diet, as previously established ([@R1]). Nocturnal dipping was calculated as the percent decline in nocturnal BP: Nocturnal Dipping % = \[(average daytime BP − average nocturnal BP)/average daytime BP\]\*100.

Blood and Urine Analysis {#S6}
------------------------

A fasted blood sample and a 24h urine collection were obtained on the final day of each diet. Blood and urine was analyzed for electrolyte concentration on each sodium diet (EasyElectrolyte Analyzer; Medica, Bedford, MA, USA). Urinary electrolyte content was calculated and normalized to 24h. Hemoglobin (Hb 201+ model, Hemocue, Lake Forest, CA, USA) and hematocrit (Pre-Calibrated Clay Adams, Readacrit Centrifuge, Becton Dickinson, Sparks, MD, USA) were analyzed from collected whole blood samples.

Statistical Analysis {#S7}
--------------------

Baseline screening anthropometrics, screening biochemical parameters, and the run-in diet were compared between men and women using unpaired *t*-Tests (GraphPad Prism 5, GraphPad Software, Inc., La Jolla, CA, USA). Participants were divided into subgroups based on sex and 2×2 (diet x sex) ANOVAs were used to compare biochemical parameters, ambulatory 24h BP (systolic, diastolic, mean arterial pressure), and nocturnal dipping. Post hoc analyses were performed using the Bonferroni method when appropriate. A two-way ANOVA was used to test for any sequencing effects, the first factor was diet and the second was the order in which participants received LS first (n=40) and HS first (n=40). The main outcome variables met the assumptions of the test (e.g. normal distribution and variance, SPSS Statistics 23, IBM, Armonk, NY). Significance was set at *p*\<0.05 and values are reported as means ± SE.

RESULTS {#S8}
=======

Baseline Characteristics {#S9}
------------------------

[Table 1](#T1){ref-type="table"} displays baseline demographic, anthropometric, and biochemical parameters (n=80) obtained during the screening visit during their habitual sodium intake. Men were younger than women participants (*p*\<0.05), however men and women had similar BMI. Height, weight, systolic BP, and mean arterial pressure were significantly greater in men compared to women (*p*\<0.05). Serum chloride, total cholesterol, and fasting HDL cholesterol were lower in men compared to women (*p*\<0.05), while hemoglobin and hematocrit were greater in men (*p*\<0.01). All participants had liver and kidney function within normal limits. All other biochemical parameters were similar during the initial screening visit between men and women.

Responses to Standardized Run-in Diet {#S10}
-------------------------------------

During the standardized run-in diet, 24h urine sodium excretion was not different between men and women ([Fig 1](#F1){ref-type="fig"}, *p*\>0.05). Systolic BP and mean arterial pressure were higher in men compared to women (see [Table 2](#T2){ref-type="table"}). Blood electrolyte analysis revealed that serum chloride was lower in men compared to women (*p*\<0.05), while men also had an expected higher hematocrit and hemoglobin levels compared to women (*p*\<0.01). Nocturnal dipping was not different between men and women (*p*\>0.05) as presented in [Table 2](#T2){ref-type="table"} and in [Figure 2](#F2){ref-type="fig"}.

Responses to Controlled LS & HS Diets {#S11}
-------------------------------------

In response to randomized HS and LS, 24h urine sodium excretion was significantly greater during HS compared to LS (main effect of diet, *p*\>0.05, see [Figure 3](#F3){ref-type="fig"}), with no differences between men and women. Men had no change in 24h BP (systolic, diastolic, and mean arterial pressure, *p*\>0.05), while women had a significant increase in systolic BP under HS (*p*\<0.05) and no difference in diastolic BP and mean arterial pressure (see [Table 3](#T3){ref-type="table"}). Hematocrit and hemoglobin were lower during HS compared to LS (main effect of diet *p*\<0.05) and this response occurred in both men and women (*p*\<0.05 for both). Serum sodium and chloride were significantly increased under HS compared to LS (*p*\<0.05) with no difference between men and women. Nocturnal BP dipping was not different between LS and HS or between sexes (*p*\>0.05), as presented in [Table 3](#T3){ref-type="table"} and [Figure 4](#F4){ref-type="fig"}. A two-way ANOVA tested for a potential confounding by sequencing effects, comparing diets and orders. The results of this analysis found no effect of order and no diet by order interaction (*p*=0.72, and *p*=0.38, respectively). A significant interaction or order effect would have suggested a potential confounding effect.

A secondary analysis was performed to examine nocturnal dipping during LS and HS diets in those with \<10% nocturnal BP decline prior to randomization. The secondary analysis was performed where participants were divided based on whether they exhibited a dipping pattern (\>10% dip in systolic BP; n=48) or non-dipping pattern (\<10% dip in systolic BP; n=32) during the standardized run-in diet. The subsequent BP dipping responses of these two groups were compared after randomization to the LS and HS diets. No differences were observed in the dipping group (LS BP dipping= 11.2±0.8%, HS BP dipping= 12.0±1.0%, *p*\>0.05) or the non-dipping group (LS BP dipping= 7.2±1.1%, HS BP dipping= 6.9±0.9%, *p*\>0.05). Further, no differences were observed between men and women when comparing dippers and non-dippers during the LS and HS diets (*p*\>0.05). Another secondary analysis was performed to determine whether individuals classified as "salt-sensitive" had impaired nocturnal dipping during the HS diet. Salt-sensitivity was defined as a 5 mmHg or more change in 24h mean arterial pressure from LS to HS, as previously described ([@R22]). Ten participants were classified as salt-sensitive (Δ mean arterial pressure = 9±1 mmHg). Among those classified as salt-sensitive, nocturnal dipping response was not different from a LS to HS diet (LS= 8.7±2.3% vs. HS= 9.1±1.5%, *p*\>0.05).

DISCUSSION {#S12}
==========

The main findings of the current study are that (1) men and women have similar nocturnal dipping responses during a standardized run-in 100 mmol sodium·day^−1^ diet, and (2) a HS diet does not blunt nocturnal dipping in normotensive men and women. Nocturnal dipping is the degree to which pressure declines during sleep periods. Impairments in circadian dipping patterns have been shown to increase cardiovascular disease risks in hypertension, diabetes, chronic kidney disease, and aldosteronism ([@R2],[@R5],[@R10],[@R13],[@R23]). Among normotensives, impaired nocturnal dipping is associated with increased cardiovascular mortality ([@R3]). However, our findings demonstrate that one week of HS loading does not impair nocturnal dipping in normotensive adults.

Impaired nocturnal dipping and high dietary sodium can have a detrimental impact on the cardiovascular system. A favorable reduction in BP during nocturnal periods reduces hemodynamic load placed on the heart, arteries, and kidneys for prolonged periods. Understanding the effects of dietary sodium on nocturnal BP decline is important because even with a normal BP, there is evidence that impaired dipping increases cardiac remodeling, left ventricular diastolic dysfunction ([@R2]), carotid-intima thickness, and the presence of carotid artery plaque formation ([@R24]). These subclinical measurements are all associated with increased future cardiovascular events and hypertension ([@R25]). Further, disturbed circadian BP patterns with no decline in nocturnal BP are associated with increased microalbuminuria and future risk of renal damage ([@R7]). Similarly, excess dietary sodium has previously been shown to have adverse cardiovascular effects leading to target organ damage ([@R26]), vascular dysfunction ([@R27]--[@R29]), and sodium dependent hypertension ([@R30]) in individuals with hypertensive and normotensive BP. Despite the increase cardiovascular risks with excess dietary sodium consumption, we observed no significant differences in nocturnal dipping during a HS diet. These findings suggest that dietary sodium does not adversely influence circadian BP patterns in normotensive adults.

Among healthy men and women, there are observed differences in BP regulation ([@R31]). Studies measuring ambulatory 24h BPs have shown men to have higher average BP than age-matched women ([@R19]), as documented during the run-in diet in the current study. The differences in 24h average BP are thought to be influenced by both the endocrine and autonomic nervous systems. In men, elevation in testosterone after puberty has been shown to increase BP and blunt dipping compared to prepubescent testosterone levels ([@R32]). While in premenopausal women, estrogen has a direct vasodilator effect on blood vessels and potentially blunts sympathetic mediated vasoconstriction ([@R33]). In healthy women, the menstrual cycle does not influence ambulatory 24h average BP during low (follicular) or high (luteal) estrogen phases of the menstrual cycle during LS and HS diets ([@R34]). In our study, average 24h systolic BP was only modestly increased from the LS to HS diet in women, with no change in systolic BP in men. Despite known sex differences in BP regulation and differences in mean 24h SBP, nocturnal dipping was not significantly different between sexes on LS and HS diets.

While our primary focus was to determine if dietary sodium altered BP dipping in normotensive men and women, we also performed a secondary analysis where we divided participants based on whether they exhibited a dipping or non-dipping response during the run-in diet. We then compared the responses between these two groups during the LS and HS diets, and found that the HS diet did not have an effect on BP dipping in adults initially classified as dippers or non-dippers. This secondary analysis is consistent with our primary conclusion that dietary sodium does not influence BP dipping in normotensive adults.

Several methodological aspects of this study strengthen the major findings. First, we utilized a controlled feeding design where a registered dietitian prepared all food. This approach is stronger and overcomes the limitations associated with self-reported dietary intake. Second, following the initial standardized run-in diet, we used a randomized cross-over design to measure nocturnal dipping under LS and HS diets. The findings of the current study builds upon previous studies examining nocturnal dipping under habitual and non-randomized sodium diets ([@R14],[@R17]). Third, a large cohort consisting of 80 normotensive adults completed the controlled feeding study with an adequate number of BPs during daytime and nocturnal periods. This was done by utilizing strict criteria of previously established guidelines set forth by O'Brien et al ([@R1]), to remove data bias and reduce the possibility of a type 1 error. Fourth, we assessed 24h urinary sodium excretion ([@R35]) to confirm compliance to the diets. Thus, this comprehensive assessment of nocturnal dipping clearly demonstrates that HS does not disrupt nocturnal dipping in healthy normotensive men and women.

A limitation to our study is that estrogen levels and menopausal status were not assessed. Nonetheless, a previous study reported that varying phases of the menstrual cycle (Iuteal & follicular phase) do not affect ambulatory 24h average BP under LS and HS diets in healthy normotensive women ([@R34]). Additionally, we excluded 21 participants from analysis for an inadequate number of BP measurements. Methods for assessing nocturnal dipping and ambulatory BP monitoring vary widely in the literature, therefore we utilized previously established criteria to reduce analysis bias ([@R1]). It is important to note that the study findings are the same when including all participants. Thus, excluding participants based on the criteria of O' Brian et al ([@R1]) did not alter the main study conclusions. Although not the focus of the current study, individuals with salt-sensitive hypertension have been shown to have impaired nocturnal dipping, and sodium restriction has been observed to improve nocturnal dipping ([@R9]). The findings of the current study found that nocturnal dipping was not altered during the HS condition among the 10 normotensive participants individually determined to be salt-sensitive.

In summary, among adults with normotensive BP, nocturnal dipping was not different between LS and HS diets. Despite known sex differences in BP regulation, dietary sodium did not influence nocturnal dipping in normotensive men and women. Thus, dietary sodium likely does not increase CVD risks through impaired nocturnal dipping in normotensive men and women. Future studies are needed to determine if dietary sodium alters other aspects of the circadian BP pattern.
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###### 

Participant Baseline Data

                                          Men           Women
  --------------------------------------- ------------- ---------------------------------------------
  **Demographic & Anthropometric Data**                 
  Number of participants                  39            41
  Race                                    W29, B6, A4   W35, B5, A1
  Age, yr.                                34 ± 2        41 ± 2[\*](#TFN2){ref-type="table-fn"}
  Height, cm                              178 ± 1       167 ± 1[\*](#TFN2){ref-type="table-fn"}
  Weight, kg                              78 ± 2        68 ± 1[\*](#TFN2){ref-type="table-fn"}
  BMI, kg·m^−2^                           25.0 ± 0.5    24.2 ± 0.4
  SBP, mmHg                               123 ± 2       116 ± 2[\*](#TFN2){ref-type="table-fn"}
  DBP, mmHg                               77 ± 1        73 ± 2
  PP, mmHg                                46 ± 1        43 ± 1
  MAP, mmHg                               92 ± 1        87 ± 1[\*](#TFN2){ref-type="table-fn"}
  Heart rate, beats·min^−1^               63 ± 1        64 ± 2
  **Biochemical Parameters**                            
  Serum sodium, mmol·L^−1^                138.6 ± 0.9   139.0 ± 0.3
  Serum potassium, mmol·L^−1^             4.50 ± 0.10   4.52 ± 0.06
  Serum chloride, mmol·L^−1^              103.8 ± 0.4   106.0 ± 0.3[\*](#TFN2){ref-type="table-fn"}
  Fasting total cholesterol, mg·dL^−1^    174 ± 5       192 ± 5[\*](#TFN2){ref-type="table-fn"}
  Fasting LDL, mg·dL^−1^                  102 ± 4       105 ± 4
  Fasting HDL, mg·dL^−1^                  54 ± 2        72 ± 3[\*](#TFN2){ref-type="table-fn"}
  Fasting triglycerides, mg·dL^−1^        92 ± 6        80 ± 5
  Blood urea nitrogen, mg·dL^−1^          14.2 ± 0.7    14.0 ± 0.6
  Hemoglobin, g·dL^−1^                    15.2 ± 0.1    13.0 ± 0.1[\*](#TFN2){ref-type="table-fn"}
  Hematocrit, %                           45 ± 0        39 ± 0[\*](#TFN2){ref-type="table-fn"}

Values are means ± SE. A, Asian; B, black; BMI, body mass index; DBP, diastolic blood pressure; HDL, high-density lipoprotein;; LDL, low-density lipoprotein; MAP, mean arterial blood pressure; PP, pulse pressure; SBP, systolic blood pressure; W, white.

*p* \<0.05 (men vs. women)

###### 

Blood Pressure and Biochemical Parameters during the Run-in Diet

                                Men           Women
  ----------------------------- ------------- ---------------------------------------------
  24h SBP, mmHg                 119 ± 1       112 ± 1[\*](#TFN4){ref-type="table-fn"}
  24h DBP, mmHg                 71 ± 1        70 ± 1
  24h MAP, mmHg                 87 ± 1        84 ± 1[\*](#TFN4){ref-type="table-fn"}
  Daytime SBP, mmHg             124 ± 1       116 ± 1[\*](#TFN4){ref-type="table-fn"}
  Daytime DBP, mmHg             75 ± 1        74 ± 1
  Daytime MAP, mmHg             90 ± 1        88 ± 1
  Nocturnal SBP, mmHg           109 ± 2       103 ± 1[\*](#TFN4){ref-type="table-fn"}
  Nocturnal DBP, mmHg           63 ± 1        61 ± 1
  Nocturnal MAP, mmHg           79 ± 1        76 ± 1[\*](#TFN4){ref-type="table-fn"}
  24h Heart Rate, bpm           67 ± 1        68 ± 1
  Daytime Heart Rate, bpm       70 ± 1        71 ± 1
  Nocturnal Heart Rate, bpm     58 ± 1        61 ± 1
  Serum Sodium, mmol·L^−1^      138.2 ± 0.5   138.4 ± 0.3
  Serum Potassium, mmol·L^−1^   4.16 ± 0.07   4.06 ± 0.09
  Serum Chloride, mmol·L^−1^    102.1 ± 0.5   105.1 ± 0.5[\*](#TFN4){ref-type="table-fn"}
  Hemoglobin, g·dL^−1^          16 ± 0.9      13 ± 0.2[\*](#TFN4){ref-type="table-fn"}
  Hematocrit, %                 43 ± 1        38 ± 1[\*](#TFN4){ref-type="table-fn"}
  Nocturnal DBP Dipping, %      14.9 ± 1.3    16.8 ± 1.2
  Nocturnal MAP Dipping, %      12.8 ± 1.1    13.8 ± 1.0

Values are means ± SE. DBP, Diastolic blood pressure; MAP, Mean arterial pressure; SBP, Systolic blood pressure.

*p* \<0.05 (men vs. women)

###### 

24h Ambulatory Blood Pressure and Biochemical Parameters Response to Dietary Sodium Manipulation in Men and Women

                                Men           Women                                                                                      
  ----------------------------- ------------- -------------------------------------------- --------------------------------------------- ----------------------------------------------------------------------------------------------------------
  24h SBP, mmHg                 119 ± 1       119 ± 1                                      112 ± 1[\*](#TFN6){ref-type="table-fn"}       114 ± 1[\*](#TFN6){ref-type="table-fn"}[†](#TFN7){ref-type="table-fn"}
  24h DBP, mmHg                 72 ± 1        71 ± 1                                       70 ± 1                                        70 ± 1
  24h MAP, mmHg                 87 ± 1        87 ± 1                                       84 ± 1[\*](#TFN6){ref-type="table-fn"}        85 ± 1[\*](#TFN6){ref-type="table-fn"}
  Daytime SBP, mmHg             122 ± 1       124 ± 1[†](#TFN7){ref-type="table-fn"}       116 ± 1[\*](#TFN6){ref-type="table-fn"}       118 ± 1[\*](#TFN6){ref-type="table-fn"}[†](#TFN7){ref-type="table-fn"}
  Daytime DBP, mmHg             76 ± 1        75 ± 1                                       74 ± 1                                        74 ± 1
  Daytime MAP, mmHg             91 ± 1        90 ± 1                                       88 ± 1[\*](#TFN6){ref-type="table-fn"}        89 ± 1
  Nocturnal SBP, mmHg           111 ± 1       111 ± 2                                      103 ± 1[\*](#TFN6){ref-type="table-fn"}       106 ± 1[\*](#TFN6){ref-type="table-fn"}
  Nocturnal DBP, mmHg           64 ± 1        64 ± 1                                       62 ± 1                                        63 ± 1
  Nocturnal MAP, mmHg           79 ± 1        80 ± 1                                       76 ± 1[\*](#TFN6){ref-type="table-fn"}        78 ± 1
  24h Heart Rate, bpm           68 ± 1        65 ± 1                                       69 ± 2                                        65 ± 1[†](#TFN7){ref-type="table-fn"}
  Daytime Heart Rate, bpm       71 ± 1        68 ± 1                                       73 ± 2                                        66 ± 2[†](#TFN7){ref-type="table-fn"}
  Nocturnal Heart Rate, bpm     60 ± 1        58 ± 1                                       61 ± 1                                        60 ± 1[†](#TFN7){ref-type="table-fn"}
  Serum Sodium, mmol·L^−1^      137.9 ± 0.4   140.0 ± 0.3[†](#TFN7){ref-type="table-fn"}   137.4 ± 0.3                                   139.5 ± 0.4[†](#TFN7){ref-type="table-fn"}
  Serum Potassium, mmol·L^−1^   4.13 ± 0.08   4.08 ± 0.05                                  4.02 ± 0.06                                   3.98 ± 0.06
  Serum Chloride, mmol·L^−1^    101.1 ± 0.5   104.0 ± 0.4[†](#TFN7){ref-type="table-fn"}   102.6 ± 0.3[\*](#TFN6){ref-type="table-fn"}   106.4 ± 0.4[\*](#TFN6){ref-type="table-fn"}[†](#TFN7){ref-type="table-fn"}
  Hemoglobin, g·dL^−1^          16.0 ± 0.9    15.3 ± 0.8[†](#TFN7){ref-type="table-fn"}    13.0 ± 0.2[\*](#TFN6){ref-type="table-fn"}    11.8 ± 0.2[\*](#TFN6){ref-type="table-fn"}[†](#TFN7){ref-type="table-fn"}[‡](#TFN8){ref-type="table-fn"}
  Hematocrit, %                 43 ± 1        42 ± 1                                       39 ± 1[\*](#TFN6){ref-type="table-fn"}        37 ± 1[\*](#TFN6){ref-type="table-fn"}[†](#TFN7){ref-type="table-fn"}[‡](#TFN8){ref-type="table-fn"}
  Nocturnal DBP Dipping, %      14.7 ± 1.4    13.8 ± 1.8                                   15.8 ± 1.3                                    14.9 ± 1.0
  Nocturnal MAP Dipping, %      12.9 ± 1.2    11.4 ± 1.4                                   12.8 ± 1.0                                    12.5 ± 0.8

Values are means ± SE. DBP, Diastolic blood pressure; MAP, Mean arterial pressure; SBP, Systolic blood pressure.

*p* \<0.05 (men vs. women);

*p* \<0.05 (low sodium vs high sodium);

*p* \<0.05 (sex x diet).

###### SUMMARY TABLE

What is known about topic {#S15}
=========================

-   High dietary sodium and impaired nocturnal blood pressure dipping have been shown to have adverse cardiovascular effects.

-   Several clinical populations, including hypertensives, have impaired blood pressure dipping when consuming a high sodium diet, which is restored during sodium restriction.

What this study adds {#S16}
====================

-   Few studies have examined nocturnal blood pressure dipping in normotensive men and women while precisely controlling dietary sodium levels.

-   The findings of the current study provide evidence that nocturnal blood pressure dipping is not different between normotensive men and women during well-controlled high and low sodium diets.

[^1]: These senior authors contributed equally to this paper.
